心血管超音波市場規模、佔有率、成長、全球產業分析、區域趨勢及2026-2034年預測。

心血管超音波市場成長要素

2025年全球心血管超音波市場規模為25.8億美元，預計將從2026年的27.4億美元成長至2034年的43.3億美元，預測期內複合年成長率（CAGR）為5.9%。北美市場佔主導地位，預計到2025年將佔33.33%的市場佔有率，這得益於其先進的醫療基礎設施、診斷成像技術的積極應用以及眾多行業領先企業的存在。

心血管超音波，俗稱心臟超音波圖，是一種非侵入性影像技術，用於即時評估心臟的解剖結構、血流、心腔大小、瓣膜功能和整體心臟功能。心血管疾病盛行率的不斷上升、早期診斷需求的日益成長以及對即時成像解決方案需求的不斷擴大，正在推動全球市場成長。

2025年，GE醫療、皇家飛利浦和西門子醫療等領導企業憑藉廣泛的心血管影像產品組合、技術創新和廣泛的全球銷售網路，保持了其市場主導地位。

心血管超音波市場趨勢

人工智慧驅動的自動化正在成為重要的市場趨勢。

人工智慧 (AI) 正在透過簡化工作流程、縮短檢查時間和提高診斷準確性來變革心血管超音波。製造商正擴大整合人工智慧工具，以實現影像採集、測量、量化和報告流程的自動化。

2024年6月，皇家飛利浦公司宣布其EPIQ CVx和Affiniti CVx系統已獲得FDA批准的人工智慧應用。這些應用包括自動評估心壁運動和對二尖瓣逆流進行3D量化。這些創新技術能夠幫助醫療專業人員提高工作效率，同時提供更一致的診斷結果。

市場促進因素

心血管疾病負擔加重，推動了市場需求。

心血管疾病盛行率的不斷上升仍然是市場成長要素。根據「美國心臟病學會雜誌」（JACC）報道，2022年約有3.15億人患有冠狀動脈疾病。隨著患者數量的成長，對診斷影像檢查、後續觀察和治療方案的指導需求也日益增加。

心血管超音波因其非侵入性、經濟、便攜以及能夠提供即時影像等優點，仍然是最受歡迎的診斷方法之一。這些優勢持續推動其在醫院、門診和急診醫療機構的廣泛應用。

市場限制因素

對專業技術人員的依賴限制了其廣泛應用。

儘管技術不斷進步，心血管超音波仍需要訓練有素的超音波技師和循環系統來獲取和解讀準確的影像。合格醫療專業人員的短缺仍然是阻礙市場成長的一大挑戰。

根據北美放射學會 (RSNA) 的說法，到 2034 年，醫生短缺人數可能達到 124,000 人，這將影響醫學影像服務的可用性，並可能限制某些地區的部署率。

市場機遇

攜帶式超音波設備與人工智慧的結合創造了成長潛力。

手持式超音波設備和人工智慧輔助成像平台的日益普及，創造了巨大的成長機會。這些技術簡化了心臟評估，使非專業人員也能獲得診斷等級的影像。

2024年4月，GE醫療為其手持式超音波診斷設備「Vscan Air SL」發布了「Caption AI」人工智慧系統，該系統可實現即時探頭引導和自動射血分數計算。預計此類創新將擴大心血管超音波在基層醫療機構、門診診所和預防心臟病計畫的應用。

市場挑戰

先進醫療影像系統高成本

具備人工智慧、3D/4D成像和先進視覺化技術的高階心血管超音波系統需要大量的資金投入。維護成本、軟體升級和使用者培訓進一步增加了擁有成本，這對預算有限的醫療機構來說是一個挑戰。

細分分析

副產品

到 2025 年，系統領域將佔最大的市場佔有率，這主要得益於對先進診斷成像平台的需求不斷成長以及全球醫療保健基礎設施的擴張。

預計在預測期內，配件和耗材細分市場將以 7.5% 的複合年成長率成長，這主要得益於檢測數量的增加以及對超音波耗材的持續需求。

用途別

預計到 2025 年，心臟結構和功能評估領域將推動市場發展，到 2026 年將佔市場佔有率的 32.7%。此領域受益於心臟超音波圖在評估心室功能、腔室尺寸和心臟形態方面的廣泛應用。

預計到 2034 年，瓣膜性心臟病評估市場將以 6.1% 的複合年成長率成長。

最終用戶

醫院和門診手術中心（ASC）將在 2025 年佔最大佔有率，預計到 2026 年將佔市場佔有率的 65.3%。這一成長是由患者數量增加、複雜心血管手術增多以及對手術全期影像的需求不斷成長所推動的。

預計在研究期間，專科診所細分市場將以 7.1% 的複合年成長率成長。

區域分析

北美洲

預計北美將成為最大的區域市場，到 2025 年市場規模將達到 8.6 億美元。強勁的醫療費用支出、先進的診斷基礎設施以及創新超音波技術的快速普及正在推動該地區的領先地位。

預計到 2026 年，美國心血管超音波市場規模將達到 8 億美元，約佔全球整體銷售額的 29.2%。

歐洲

預計在預測期內，歐洲的複合年成長率將達到 5.3%，到 2026 年將達到 7.2 億美元。這一成長得益於強大的醫院網路、影像中心和技術精湛的放射學專業人員。

預計到 2026 年，德國市場規模將達到 1.5 億美元，而英國市場規模預計將達到 1.2 億美元。

亞太地區

預計到2026年，亞太地區市場規模將達到約8億美元，成為全球第二大區域市場。心血管疾病盛行率上升、醫療基礎設施改善以及診斷影像領域投資增加是推動該地區市場成長的主要因素。

預計到 2026 年，中國市場規模將達到 2.8 億美元，日本市場規模將達到 1.5 億美元，印度市場規模將達到 1.1 億美元。

拉丁美洲、中東和非洲

由於醫療保健服務的改善和人們對心血管疾病早期診斷意識的提高，預計這些地區將實現穩步成長。拉丁美洲市場預計到2026年將達到1.9億美元，海灣合作理事會（GCC）市場預計為5,000萬美元。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

• 市場促進因素
• 市場限制因素
• 市場機遇
• 市場趨勢

第4章：主要考慮因素

• 主要疾病盛行率（按主要國家分類，2025 年）
• 心血管超音波診斷的進展
• 關鍵產業趨勢－（合併、收購、合作等）

第5章：2021-2034年全球心血管超音波市場分析、洞察與預測

• 市場分析、洞察與預測：按產品分類。
  • 系統
  • 配件和耗材
• 市場分析、洞察與預測：按應用領域分類
  • 心臟結構和功能的評估
  • 心臟瓣膜疾病的評估
  • 心臟衰竭和心肌病的評估
  • 冠狀動脈和血管成像引導
  • 先天性心臟疾病的評估
  • 其他
• 市場分析、洞察與預測：按最終用戶分類
  • 醫院及日間手術中心
  • 專科診所
  • 診斷影像中心
  • 其他
• 市場分析、洞察與預測：按地區分類
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第6章：北美心血管超音波市場分析、洞察與預測（2021-2034年）

• 國家
  • 美國
  • 加拿大

第7章：歐洲心血管超音波市場分析、洞察與預測（2021-2034年）

• 國家
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 斯堪地那維亞
  • 其他歐洲國家

第8章：亞太地區心血管超音波市場分析、洞察與預測（2021-2034年）

• 國家
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 東南亞
  • 其他亞太國家

第9章：拉丁美洲心血管超音波市場分析、洞察與預測（2021-2034年）

• 國家
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家

第10章：中東和非洲心血管超音波市場分析、洞察與預測（2021-2034年）

• 國家
  • 南非
  • GCC
  • 其他中東和非洲國家

第11章 競爭分析

• 全球市佔率分析（2025 年）
• 公司簡介
  • GE HealthCare
  • Koninklijke Philips NV
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Esaote SPA
  • SonoScape Medical Corp
  • Butterfly Network, inc
  • Konica Minolta, Inc.

Growth Factors of cardiovascular ultrasound Market

The global cardiovascular ultrasound market size was valued at USD 2.58 billion in 2025 and is projected to grow from USD 2.74 billion in 2026 to USD 4.33 billion by 2034, exhibiting a CAGR of 5.9% during the forecast period. North America dominated the market with a 33.33% market share in 2025, supported by advanced healthcare infrastructure, strong adoption of diagnostic imaging technologies, and the presence of leading industry participants.

Cardiovascular ultrasound, commonly known as echocardiography, is a non-invasive imaging technology used to assess heart anatomy, blood flow, chamber dimensions, valve performance, and overall cardiac function in real time. Growing prevalence of cardiovascular diseases, increasing need for early diagnosis, and rising demand for point-of-care imaging solutions are driving market expansion worldwide.

Leading companies such as GE HealthCare, Koninklijke Philips N.V., and Siemens Healthineers maintained a dominant market position in 2025 due to their extensive cardiovascular imaging portfolios, technological innovations, and broad global distribution networks.

Cardiovascular Ultrasound Market Trends

AI-Driven Automation Emerging as a Key Market Trend

Artificial intelligence is transforming cardiovascular ultrasound by improving workflow efficiency, reducing examination time, and enhancing diagnostic accuracy. Manufacturers are increasingly integrating AI-powered tools that automate image acquisition, measurement, quantification, and reporting processes.

In June 2024, Koninklijke Philips N.V. introduced FDA-cleared AI applications for its EPIQ CVx and Affiniti CVx systems, including automated wall motion scoring and 3D quantification of mitral regurgitation. Such innovations are helping healthcare providers improve productivity while delivering more consistent diagnostic outcomes.

Market Drivers

Rising Cardiovascular Disease Burden Fueling Demand

The growing incidence of cardiovascular disorders remains the primary growth driver for the market. According to the Journal of the American College of Cardiology (JACC), approximately 315 million people were living with coronary artery disease in 2022. The increasing patient population requires frequent diagnostic imaging, follow-up monitoring, and procedural guidance.

Cardiovascular ultrasound remains one of the most preferred diagnostic modalities due to its non-invasive nature, affordability, portability, and ability to provide real-time imaging. These advantages continue to support widespread adoption across hospitals, outpatient centers, and emergency care settings.

Market Restraints

Dependence on Skilled Professionals Limiting Adoption

Despite technological advancements, cardiovascular ultrasound examinations require trained sonographers and cardiologists for accurate image acquisition and interpretation. Shortages of qualified healthcare professionals continue to challenge market growth.

According to the Radiological Society of North America (RSNA), physician shortages could range from 37,800 to 124,000 professionals by 2034, potentially impacting imaging service availability and limiting adoption rates in several regions.

Market Opportunities

Handheld Ultrasound and AI Integration Creating Growth Potential

The increasing adoption of handheld ultrasound devices and AI-assisted imaging platforms is creating significant growth opportunities. These technologies simplify cardiac assessments and enable non-specialists to obtain diagnostic-quality images.

In April 2024, GE HealthCare launched Caption AI on the Vscan Air SL handheld ultrasound system, enabling real-time probe guidance and automated ejection fraction calculations. Such innovations are expected to expand cardiovascular ultrasound usage in rural healthcare facilities, ambulatory centers, and preventive cardiology programs.

Market Challenges

High Cost of Advanced Imaging Systems

Premium cardiovascular ultrasound systems equipped with AI capabilities, 3D/4D imaging, and advanced visualization technologies require substantial capital investment. Maintenance costs, software upgrades, and user training further increase ownership expenses, creating challenges for healthcare facilities with limited budgets.

Segmentation Analysis

By Product

The systems segment held the largest market share in 2025 due to increasing demand for advanced imaging platforms and expansion of healthcare infrastructure globally.

The accessories & consumables segment is expected to register a CAGR of 7.5% during the forecast period owing to growing procedural volumes and recurring demand for ultrasound consumables.

By Application

The cardiac structure and function assessment segment dominated the market in 2025 and is projected to account for 32.7% of the market in 2026. The segment benefits from widespread use of echocardiography for evaluating ventricular function, chamber dimensions, and cardiac morphology.

The valvular heart disease assessment segment is anticipated to grow at a CAGR of 6.1% through 2034.

By End User

Hospitals & ASCs accounted for the largest share in 2025 and are projected to represent 65.3% of the market in 2026. Growth is driven by increasing patient admissions, complex cardiac procedures, and rising demand for perioperative imaging.

The specialty clinics segment is forecast to expand at a CAGR of 7.1% during the study period.

Regional Analysis

North America

North America generated USD 0.86 billion in 2025, making it the largest regional market. Strong healthcare spending, advanced diagnostic infrastructure, and rapid adoption of innovative ultrasound technologies support regional dominance.

The U.S. cardiovascular ultrasound market is expected to reach USD 0.80 billion in 2026, representing approximately 29.2% of global revenue.

Europe

Europe is projected to grow at a 5.3% CAGR during the forecast period and reach USD 0.72 billion in 2026. Growth is supported by a strong network of hospitals, diagnostic imaging centers, and trained radiology professionals.

Germany is expected to reach USD 0.15 billion in 2026, while the U.K. market is projected to attain USD 0.12 billion.

Asia Pacific

Asia Pacific is anticipated to become the second-largest regional market, reaching approximately USD 0.80 billion in 2026. Rising cardiovascular disease prevalence, healthcare infrastructure development, and increasing investments in diagnostic imaging are driving regional growth.

China is projected to generate USD 0.28 billion, Japan USD 0.15 billion, and India USD 0.11 billion in 2026.

Latin America and Middle East & Africa

These regions are expected to witness steady growth due to improving healthcare accessibility and increasing awareness regarding early cardiovascular disease diagnosis. Latin America is projected to reach USD 0.19 billion by 2026, while the GCC market is estimated at USD 0.05 billion.

Competitive Landscape

The cardiovascular ultrasound market remains highly competitive, led by GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Esaote SPA, SonoScape Medical Corp, Butterfly Network, Inc., and Konica Minolta, Inc.

Major companies are focusing on AI-enabled imaging platforms, product launches, strategic collaborations, acquisitions, and geographic expansion to strengthen their market positions.

Key Industry Developments

• August 2025: Philips launched Transcend Plus for EPIQ CVx and Affiniti CVx with enhanced AI capabilities.
• March 2025: FUJIFILM partnered with Us2.ai to integrate AI-driven echocardiography analysis into LISENDO workflows.
• August 2024: Siemens Healthineers received FDA clearance for ACUSON Origin and AcuNav Lumos 4D ICE catheter.
• June 2024: Philips introduced next-generation AI-enabled cardiovascular ultrasound solutions.
• April 2024: FUJIFILM launched the OPIE transducer for intracardiac echocardiography imaging.
• January 2024: Butterfly Network received FDA clearance for Butterfly iQ3 handheld ultrasound.
• October 2023: GE HealthCare launched Caption AI on the Vscan Air SL platform.

Conclusion

The cardiovascular ultrasound market is poised for steady expansion, growing from USD 2.58 billion in 2025 to USD 2.74 billion in 2026 and reaching USD 4.33 billion by 2034. Rising cardiovascular disease prevalence, growing adoption of AI-powered imaging solutions, increasing utilization of handheld ultrasound devices, and expanding healthcare infrastructure are expected to drive market growth. Although challenges such as skilled workforce shortages and high equipment costs persist, continuous technological innovation and broader access to advanced diagnostic imaging are likely to create significant opportunities for industry participants throughout the forecast period.

Segmentation By Product, Application, End-user, and Region

By Product * Systems

• Accessories & Consumables

By Application * Cardiac Structure and Function Assessment

• Valvular Heart Disease Assessment
• Heart Failure and Cardiomyopathy Evaluation
• Coronary and Vascular Imaging Guidance
• Congenital Heart Disease Assessment
• Others

By End-user * Hospitals & ASCs

• Specialty Clinics
• Diagnostic Imaging Centers
• Others

By Region * North America (By Product, Application, End-user, and Country)

• U.S. (By Product)
• Canada (By Product)
• Europe (By Product, Application, End-user, and Country/Sub-region)
  • Germany (By Product)
  • U.K. (By Product)
  • France (By Product)
  • Spain (By Product)
  • Italy (By Product)
  • Scandinavia (By Product)
  • Rest of Europe (By Product)
• Asia Pacific (By Product, Application, End-user, and Country/Sub-region)
  • China (By Product)
  • Japan (By Product)
  • India (By Product)
  • Australia (By Product)
  • Southeast Asia (By Product)
  • Rest of Asia Pacific (By Product)
• Latin America (By Size, Procedure, End-user, and Country/Sub-region)
  • Brazil (By Product)
  • Mexico (By Product)
  • Rest of Latin America (By Product)
• Middle East & Africa (By Product, Application, End-user, and Country/Sub-region)
  • GCC (By Product)
  • South Africa (By Product)
  • Rest of the Middle East & Africa (By Product)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Conditions, by key Country/Region, 2025
• 4.2. Advancements in Cardiovascular Ultrasound
• 4.3. Key Industry Developments - (Mergers, Acquisitions & Partnerships, etc.)

5. Global Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Systems
  • 5.1.2. Accessories & Consumables
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Cardiac Structure and Function Assessment
  • 5.2.2. Valvular Heart Disease Assessment
  • 5.2.3. Heart Failure and Cardiomyopathy Evaluation
  • 5.2.4. Coronary and Vascular Imaging Guidance
  • 5.2.5. Congenital Heart Disease Assessment
  • 5.2.6. Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals & ASCs
  • 5.3.2. Specialty Clinics
  • 5.3.3. Diagnostic Imaging Centers
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Systems
  • 6.1.2. Accessories & Consumables
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Cardiac Structure and Function Assessment
  • 6.2.2. Valvular Heart Disease Assessment
  • 6.2.3. Heart Failure and Cardiomyopathy Evaluation
  • 6.2.4. Coronary and Vascular Imaging Guidance
  • 6.2.5. Congenital Heart Disease Assessment
  • 6.2.6. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospitals & ASCs
  • 6.3.2. Specialty Clinics
  • 6.3.3. Diagnostic Imaging Centers
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
    • 6.4.1.1. By Product
  • 6.4.2. Canada
    • 6.4.2.1. By Product

7. Europe Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Systems
  • 7.1.2. Accessories & Consumables
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Cardiac Structure and Function Assessment
  • 7.2.2. Valvular Heart Disease Assessment
  • 7.2.3. Heart Failure and Cardiomyopathy Evaluation
  • 7.2.4. Coronary and Vascular Imaging Guidance
  • 7.2.5. Congenital Heart Disease Assessment
  • 7.2.6. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospitals & ASCs
  • 7.3.2. Specialty Clinics
  • 7.3.3. Diagnostic Imaging Centers
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.4.1. Germany
    • 7.4.1.1. By Product
  • 7.4.2. U.K.
    • 7.4.2.1. By Product
  • 7.4.3. France
    • 7.4.3.1. By Product
  • 7.4.4. Italy
    • 7.4.4.1. By Product
  • 7.4.5. Spain
    • 7.4.5.1. By Product
  • 7.4.6. Scandinavia
    • 7.4.6.1. By Product
  • 7.4.7. Rest of Europe
    • 7.4.7.1. By Product

8. Asia Pacific Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Systems
  • 8.1.2. Accessories & Consumables
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Cardiac Structure and Function Assessment
  • 8.2.2. Valvular Heart Disease Assessment
  • 8.2.3. Heart Failure and Cardiomyopathy Evaluation
  • 8.2.4. Coronary and Vascular Imaging Guidance
  • 8.2.5. Congenital Heart Disease Assessment
  • 8.2.6. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospitals & ASCs
  • 8.3.2. Specialty Clinics
  • 8.3.3. Diagnostic Imaging Centers
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.4.1. China
    • 8.4.1.1. By Product
  • 8.4.2. India
    • 8.4.2.1. By Product
  • 8.4.3. Japan
    • 8.4.3.1. By Product
  • 8.4.4. Australia
    • 8.4.4.1. By Product
  • 8.4.5. Southeast Asia
    • 8.4.5.1. By Product
  • 8.4.6. Rest of Asia Pacific
    • 8.4.6.1. By Product

9. Latin America Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Systems
  • 9.1.2. Accessories & Consumables
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Cardiac Structure and Function Assessment
  • 9.2.2. Valvular Heart Disease Assessment
  • 9.2.3. Heart Failure and Cardiomyopathy Evaluation
  • 9.2.4. Coronary and Vascular Imaging Guidance
  • 9.2.5. Congenital Heart Disease Assessment
  • 9.2.6. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospitals & ASCs
  • 9.3.2. Specialty Clinics
  • 9.3.3. Diagnostic Imaging Centers
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.4.1. Brazil
    • 9.4.1.1. By Product
  • 9.4.2. Mexico
    • 9.4.2.1. By Product
  • 9.4.3. Rest of Latin America
    • 9.4.3.1. By Product

10. Middle East & Africa Cardiovascular Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product
  • 10.1.1. Systems
  • 10.1.2. Accessories & Consumables
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Cardiac Structure and Function Assessment
  • 10.2.2. Valvular Heart Disease Assessment
  • 10.2.3. Heart Failure and Cardiomyopathy Evaluation
  • 10.2.4. Coronary and Vascular Imaging Guidance
  • 10.2.5. Congenital Heart Disease Assessment
  • 10.2.6. Others
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Hospitals & ASCs
  • 10.3.2. Specialty Clinics
  • 10.3.3. Diagnostic Imaging Centers
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.4.1. South Africa
    • 10.4.1.1. By Product
  • 10.4.2. GCC
    • 10.4.2.1. By Product
  • 10.4.3. Rest of Middle East & Africa
    • 10.4.3.1. By Product

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. GE HealthCare
  • 11.2.2. Koninklijke Philips N.V.
  • 11.2.3. Siemens Healthineers
  • 11.2.4. Canon Medical Systems Corporation
  • 11.2.5. Fujifilm Holdings Corporation
  • 11.2.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 11.2.7. Esaote SPA
  • 11.2.8. SonoScape Medical Corp
  • 11.2.9. Butterfly Network, inc
  • 11.2.10. Konica Minolta, Inc.

List of Tables

• Figure 1: Global Cardiovascular Ultrasound Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
• Figure 2: Global Cardiovascular Ultrasound Market Value Share (%), by Product, 2025 & 2034
• Figure 3: Global Cardiovascular Ultrasound Market Value Share (%), by Application, 2025 & 2034
• Figure 4: Global Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025 & 2034
• Figure 5: Global Cardiovascular Ultrasound Market Value (USD billion), by Region, 2025 & 2034
• Figure 6: North America Cardiovascular Ultrasound Market Value (USD billion), by Product, 2025 & 2034
• Figure 7: North America Cardiovascular Ultrasound Market Value Share (%), by Product, 2025
• Figure 8: North America Cardiovascular Ultrasound Market Value (USD billion), by Application, 2025 & 2034
• Figure 9: North America Cardiovascular Ultrasound Market Value Share (%), by Application, 2025
• Figure 10: North America Cardiovascular Ultrasound Market Value (USD billion), by End-user, 2025 & 2034
• Figure 11: North America Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025
• Figure 12: North America Cardiovascular Ultrasound Market Value (USD billion), By Country, 2025 & 2034
• Figure 13: North America Cardiovascular Ultrasound Market Value Share (%), By Country, 2025
• Figure 14: Europe Cardiovascular Ultrasound Market Value (USD billion), by Product, 2025 & 2034
• Figure 15: Europe Cardiovascular Ultrasound Market Value Share (%), by Product, 2025
• Figure 16: Europe Cardiovascular Ultrasound Market Value (USD billion), by Application, 2025 & 2034
• Figure 17: Europe Cardiovascular Ultrasound Market Value Share (%), by Application, 2025
• Figure 18: Europe Cardiovascular Ultrasound Market Value (USD billion), by End-user, 2025 & 2034
• Figure 19: Europe Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025
• Figure 20: Europe Cardiovascular Ultrasound Market Value (USD billion), By Country/Sub-region, 2025 & 2034
• Figure 21: Europe Cardiovascular Ultrasound Market Value Share (%), By Country/Sub-region, 2025
• Figure 22: Asia Pacific Cardiovascular Ultrasound Market Value (USD billion), by Product, 2025 & 2034
• Figure 23: Asia Pacific Cardiovascular Ultrasound Market Value Share (%), by Product, 2025
• Figure 24: Asia Pacific Cardiovascular Ultrasound Market Value (USD billion), by Application, 2025 & 2034
• Figure 25: Asia Pacific Cardiovascular Ultrasound Market Value Share (%), by Application, 2025
• Figure 26: Asia Pacific Cardiovascular Ultrasound Market Value (USD billion), by End-user, 2025 & 2034
• Figure 27: Asia Pacific Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025
• Figure 28: Asia Pacific Cardiovascular Ultrasound Market Value (USD billion), By Country/Sub-region, 2025 & 2034
• Figure 29: Asia Pacific Cardiovascular Ultrasound Market Value Share (%), By Country/Sub-region, 2025
• Figure 30: Latin America Cardiovascular Ultrasound Market Value (USD billion), by Product, 2025 & 2034
• Figure 31: Latin America Cardiovascular Ultrasound Market Value Share (%), by Product, 2025
• Figure 32: Latin America Cardiovascular Ultrasound Market Value (USD billion), by Application, 2025 & 2034
• Figure 33: Latin America Cardiovascular Ultrasound Market Value Share (%), by Application, 2025
• Figure 34: Latin America Cardiovascular Ultrasound Market Value (USD billion), by End-user, 2025 & 2034
• Figure 35: Latin America Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025
• Figure 36: Latin America Cardiovascular Ultrasound Market Value (USD billion), By Country/Sub-region, 2025 & 2034
• Figure 37: Latin America Cardiovascular Ultrasound Market Value Share (%), By Country/Sub-region, 2025
• Figure 38: Middle East & Africa Cardiovascular Ultrasound Market Value (USD billion), by Product, 2025 & 2034
• Figure 39: Middle East & Africa Cardiovascular Ultrasound Market Value Share (%), by Product, 2025
• Figure 40: Middle East & Africa Cardiovascular Ultrasound Market Value (USD billion), by Application, 2025 & 2034
• Figure 41: Middle East & Africa Cardiovascular Ultrasound Market Value Share (%), by Application, 2025
• Figure 42: Middle East & Africa Cardiovascular Ultrasound Market Value (USD billion), by End-user, 2025 & 2034
• Figure 43: Middle East & Africa Cardiovascular Ultrasound Market Value Share (%), by End-user, 2025
• Figure 44: Middle East & Africa Cardiovascular Ultrasound Market Value (USD billion), By Country/Sub-region, 2025 & 2034
• Figure 45: Middle East & Africa Cardiovascular Ultrasound Market Value Share (%), By Country/Sub-region, 2025
• Figure 46: Global Cardiovascular Ultrasound Market Share (%), By Company, 2025